[HTML] springer.com

[HTML][HTML] New tetracyclic systems integrated thienopyridine scaffold as an anti-dementia lead: in silico study and biological screening

Z Mahmoud, LW Mohamed, KO Mohamed… - Medicinal Chemistry …, 2023 - Springer
Alzheimer's disease (AD) is a multifactorial incurable neurodegenerative disorder. To date,
cholinesterase inhibitors (ChEI) are the mainstay line of treatment to ameliorate the …
被引用次数：3 相关文章
[PDF] academia.edu

[PDF][PDF] New tetracyclic systems integrated thienopyridine scaffold as an anti-dementia lead: in silico study and biological screening

Z Mahmoud, LW Mohamed, KO Mohamed, HS Sayed… - 2023 - academia.edu
Alzheimer's disease (AD) is a multifactorial incurable neurodegenerative disorder. To date,
cholinesterase inhibitors (ChEI) are the mainstay line of treatment to ameliorate the …

New Tetracyclic Systems Integrated Thienopyridine Scaffold As An Anti-Dementia Lead: In Silico Study And Biological Screening

Z Mahmoud, LW Mohamed, KO Mohamed, HS Sayed… - 2022 - researchsquare.com
Alzheimer's disease (AD) is a multifactorial incurable neurodegenerative disorder. To date,
cholinesterase inhibitors (ChEI) are the mainstay line of treatment to ameliorate the …

New Tetracyclic Systems Integrated Thienopyridine Scaffold As An Anti-Dementia Lead: In Silico Study And Biological Screening

Z Mahmoud, LW Mohamed, KO Mohamed, HS Sayed… - 2022 - europepmc.org
Alzheimer's disease (AD) is a multifactorial incurable neurodegenerative disorder. To date,
cholinesterase inhibitors (ChEI) are the mainstay line of treatment to ameliorate the …
[PDF] academia.edu

[PDF][PDF] New Tetracyclic Systems Integrated Thienopyridine Scaffold As An Anti-Dementia Lead: In Silico Study And Biological Screening

Z Mahmoud, LW Mohamed, KO Mohamed, HS Sayed… - academia.edu
Alzheimer's disease (AD) is a multifactorial incurable neurodegenerative disorder. To date,
cholinesterase inhibitors (ChEI) are the mainstay line of treatment to ameliorate the …